Table 1 Comparison of clinical characteristics between bacterial cervical lymphadenitis and lymphadenopathy KD patients
Characteristics | Lymphadenopathy KD (N = 403) | BCL (N = 101) | P value |
|---|---|---|---|
Age (months) | 36.0 (19.6–55.0) | 68.5 (45.6–89.2) | < 0.001 |
Male, n (%) | 253 (63.1%) | 64 (63.4%) | 0.959 |
Days of fever before treatment (days) | 4.0 (3.0–5.0) | 3.0 (2.0–5.0) | 0.005 |
WBC (× 109/L) | 14.2 (11.1–17.8) | 14.9 (11.3–19.5) | 0.310 |
ANC (× 109/L) | 10.8 (8.6–14.4) | 10.4 (7.4–16.2) | 0.214 |
CRP (mg/L) | 78.4 (45.2–111.7) | 53.7 (18.9–99.8) | 0.002 |
HB (g/L) | 112.0 ± 11.8 | 119.4 ± 9.7 | < 0.001 |
PLT (× 109/L) | 337 (279–418) | 298 (258–360) | 0.013 |
ALB (g/L) | 41.4 ± 6.8 | 43.7 ± 3.1 | < 0.001 |
ALT (U/L) | 34 (17.0–117.0) | 14 (10.0–19.0) | < 0.001 |
AST (U/L) | 38 (27.0–63.0) | 27 (22.0–32.0) | < 0.001 |
D-Dimer (ug/ml) | 1.4 (0.9–2.3) | 1.2 (0.7–1.4) | < 0.001 |
ESR (mm/h) | 51 (38.0–61.0) | 47 (31.0–58.0) | 0.096 |
NT-proBNP (pg/ml) | 523 (230.0–1690.0) | 121 (72.0–234.0) | 0.001 |
Pulmonary involvements, n (%) | 142 (40.5%) | 16 (20.0%) | < 0.001 |
Hepatosplenomegaly, n (%) | 203 (55.8%) | 27 (31.4%) | < 0.001 |
Pyuria, n (%) | 124 (43.8%) | 7 (7.2%) | < 0.001 |
Ultrasound | |||
 Bilateral cervical lymphadenopathy, n (%) | 327 (81.1%) | 63 (64.9%) | 0.001 |
 Abscess, n (%) | 2 (0.5%) | 5 (5.0%) | 0.001 |
 Liquefaction, n (%) | 0 (0.0%) | 7 (6.9%) | < 0.001 |
 Maximum lymph node diameter (mm) | 12.0 (10.0–21.0) | 24.0 (19.5–29.5) | < 0.001 |
Complications | |||
 Parotitis, n (%) | 6 (1.5%) | 7 (6.9%) | 0.002 |
 Suppurative tonsillitis, n (%) | 6 (1.5%) | 7 (6.9%) | 0.002 |
 Submandibular gland enlargement, n (%) | 0 (0.0%) | 2 (2.0%) | 0.005 |
 AARS, n (%) | 8 (2.0%) | 3 (3.0%) | 0.545 |